HLA-C Genotyping Reveals Haplotype C07 as a Potential Biomarker of Late Psoriasis Onset in Moroccan Patients

Psoriasis still has an unknown etiology. Genetic predisposition shows the association between HLA-Cw6 allele and psoriasis. Although biotherapies have been proven effective in psoriasis treatment, methotrexate (MTX) is still used as a first-line systemic therapy due to its efficacy/affordability, bu...

Full description

Saved in:
Bibliographic Details
Published inCurrent Issues in Molecular Biology Vol. 45; no. 2; pp. 1012 - 1023
Main Authors Benlabsir, Chaimaa, Riyad, Myriam, Saik, Imane El Idrissi, Ettayebi, Hanaa, Aazzane, Oussama, Nassar, Kawtar, Zaher, Soukaina, Bennani, Siham, Admou, Brahim, Housbane, Samy, Sadki, Khalid, Chiheb, Soumiya, Fellah, Hassan
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 25.01.2023
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Psoriasis still has an unknown etiology. Genetic predisposition shows the association between HLA-Cw6 allele and psoriasis. Although biotherapies have been proven effective in psoriasis treatment, methotrexate (MTX) is still used as a first-line systemic therapy due to its efficacy/affordability, but the differential response to MTX is mostly related to interindividual genetic variability and remains an issue. Our study aimed to analyze HLA-C allele frequencies in a sample of Moroccan psoriatic patients and assess the therapeutic response to MTX. Whole blood of 54 Moroccan psoriatic patients was collected and DNA was extracted. Patients’ HLA-C locus was genotyped by PCR-SSO. Results were analyzed with Luminex xMAP Technology and Match-it DNA Evolution 3.4. HLA-C typing results of 77 sex- and age-matched unrelated non-psoriatic healthy subjects were included. We observed no difference in the allelic distribution of HLA-C between patients and healthy controls, suggesting that none of the HLA-C alleles were significantly associated with psoriasis. Moreover, the HLA-C*07 allele was associated with a late age at disease onset (>30 years old) (p = 0.007). No statistically significant association was found between HLA-C allele expression and response to MTX, despite a higher frequency of HLA-C*06 in responders compared to non-responders. Thus, HLA-C*07 could be a biomarker of late psoriasis onset in the Moroccan population.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1467-3045
1467-3037
1467-3045
DOI:10.3390/cimb45020066